Temasek Holdings

Temasek Holdings is an investment company based in Singapore, founded in 1974, with a diverse portfolio valued at approximately S$242 billion. The firm invests across various sectors, including telecommunications, media and technology, financial services, transportation, consumer products, real estate, life sciences, agriculture, and energy. Temasek's investment strategy is guided by long-term trends, focusing on themes such as transforming economies, rising middle-income populations, and emerging champions. Its investment structure includes a mix of liquid assets, listed and unlisted holdings, and private equity, reflecting a commitment to being a significant shareholder in both local and international businesses. Temasek Capital Management, a subsidiary, specializes in private equity and mid-stage technology and life sciences investments, further enhancing Temasek's global investment footprint.

John Marren

Senior Managing Director

Lim Ming Pey

Associate Director

Past deals in Series B

Amogy

Series B in 2023
Amogy is a start-up, located in Brooklyn, New York and is working on a novel carbon-free energy storage system using ammonia as a fuel.

Ionblox

Series B in 2023
Zenlabs has developed proprietary silicon-based formulations that offer higher specific capacity, longer cycle life, and lower cost. Zenlabs' anodes are unique in their high loading level and high active silicon content. In addition, Zenlabs has solved the common problems with silicon based anodes such as poor cycling and swelling. Zenlabs combines these high capacity anodes with high capacity cathode materials in large format pouch cells to achieve energy densities that are much higher than what is commercially available.

Pasqal

Series B in 2023
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

DotPe

Series B in 2022
DotPe is a commerce and payments platform seeking to disrupt the payment experience by increasing customer engagement and offering catalog discovery. The technology start-up provides an offline enterprise business with a commerce and payments platform to drive digital transformation in the way they sell, manage, and engage their customers. It enables businesses to sell more, sell directly, and sell more efficiently. It was founded in 2019 by Anurag Gupta, Gyanesh Sharma, and Shailaz Nag, and its headquarters are located in Gurgaon, Haryana, India.

OnPoint

Series B in 2022
OnPoint is delivering secure IT infrastructure, enterprise systems and solutions for the U.S. federal government.

Jaguar Microsystems

Series B in 2022
Jaguar Microsystems is a technology company specializing in cloud computing and data processing solutions for data centers. Founded by Dr. Sunny Siu in 2020, the company develops data processing unit (DPU) chips aimed at enhancing the efficiency of data processing for its clients. Jaguar Microsystems offers products that feature accelerated Remote Direct Memory Access (RDMA) and RoCE, specifically designed for data center applications. The company targets domestic cloud service providers, telecommunications, and Internet service providers while also expanding its reach to meet the demands of the global market.

TeraWatt Technology

Series B in 2022
TeraWatt Technology Inc., founded in 2017 and headquartered in Santa Clara, California, with a subsidiary in Tokyo, Japan, specializes in the design and development of lithium-ion rechargeable batteries. The company's focus is on creating batteries that combine high energy density, power density, and safety, catering to various electrified applications. By leveraging advanced engineering and production techniques, TeraWatt Technology aims to provide industrial clients with long-lasting, safe, and reliable power solutions, thereby enhancing the performance of their electrified systems.

Brightseed

Series B in 2022
Brightseed, Inc. is a biotechnology company that specializes in discovering clinically beneficial molecules found in plants through its innovative Forager platform. Founded in 2017 and based in San Francisco, California, the company employs artificial intelligence and machine learning algorithms to screen plant genes, identifying the most effective sources for addressing various health conditions. By uncovering naturally occurring compounds with potential health benefits, Brightseed aims to enhance the quality of life and support chronic disease management. The company’s mission is to strengthen the connection between people and plants, ultimately facilitating a healthier future for individuals and communities.

waresix

Series B in 2022
Waresix is a logistics platform for freight-forwarding, warehouse, and land transportation. It is a platform that matches unused warehouse space with users in need of such facility, looks to capitalize on the demand for flexible warehousing given the booming e-commerce market in the country. Waresix provides a solution for dynamic warehousing strategy that allows customers, retailer, distributor, and manufacturer to quickly adapt to variable demand. Waresix is headquartered in Jakarta, Indonesia.

Wildtype

Series B in 2022
Wild Type, Inc. is a San Francisco-based company that produces meat, poultry, and seafood through cellular agriculture, eliminating the need for raising or slaughtering animals. Founded in 2016, Wild Type offers a sustainable alternative to traditional food sources, addressing critical issues such as climate change, food security, and public health. By leveraging advanced cellular agriculture technologies, the company aims to redefine how society sources healthy and delicious meat, contributing to a more sustainable food ecosystem.

AMBER AI

Series B in 2022
Amber Group is a prominent cryptocurrency financial services provider based in Hong Kong, established in 2017 by finance professionals with backgrounds in major institutions. The company offers a range of services, including cryptocurrency trading, yield enhancement, collateralized lending, decentralized finance, and electronic market making. With a global presence that includes locations in Taipei, Seoul, and Vancouver, Amber Group operates continuously to serve over 200 institutional clients, facilitating trading across more than 60 electronic exchanges. The firm has cumulatively traded over $200 billion, maintaining an average daily trading volume between $100 million and $200 million. Amber Group emphasizes the integration of advanced technology with quantitative research to enhance investment flexibility, maximize returns, and deliver sustained value to its clients.

Soul Machines

Series B in 2022
Soul Machines Limited develops emotionally responsive avatars that augment and enrich the user experience for artificial intelligence (AI) platforms. The company’s products include Digital DNA Studio, which allows user to build custom digital people for customer care, sales and marketing, brand and influencer, product, wellbeing, people and performance, training and education, and digital innovation purposes. The company was incorporated in 2016 and is headquartered in Auckland, New Zealand with additional offices in San Francisco and Los Angeles, California; New York, New York; London, United Kingdom; Tokyo, Japan; and Melbourne, Australia.

Waterdrop

Series B in 2022
Waterdrop is a producer of innovative water-based beverages designed to enhance hydration and wellness. The company offers a unique product in the form of small, sugar-free, dissolvable cubes that transform plain water into flavorful drinks. These micro drinks are enriched with vitamins and extracts sourced from high-quality natural ingredients, including fruits and plants. This approach allows consumers to enjoy a refreshing beverage without added sugars while promoting adequate hydration. Waterdrop emphasizes the use of environmentally friendly raw materials, aligning its products with sustainable practices.

H2Pro

Series B in 2022
H2Pro, Ltd. is a company that specializes in innovative water-splitting technology aimed at producing hydrogen fuel. Founded in 2019 and based in Caesarea, Israel, H2Pro has developed a proprietary electrolysis method known as E-TAC (Electrochemical–Thermally-Activated Chemical water splitting). This technology effectively separates the hydrogen and oxygen evolution reactions, offering a super-efficient approach to green hydrogen production.

Wenext

Series B in 2021
Founded in 2014, Wenext has since produced more than 15 million parts. With our large and efficient digital production facilities and systems, we could produce high-quality parts; reduce operation cost and production time, as short as 1 day. ISO 9001 certified.

Commonwealth Fusion

Series B in 2021
Commonwealth Fusion Systems LLC is a research company focused on developing fusion energy as a sustainable solution to combat climate change. Established in 2017 and based in Cambridge, Massachusetts, the company utilizes advanced rare-earth barium copper oxide superconductor technology to create energy through fusion. Commonwealth Fusion Systems combines decades of government-funded fusion research with innovative superconducting magnet technology to expedite the commercialization of fusion energy. The company emerged from the Massachusetts Institute of Technology and collaborates closely with MIT’s Plasma Science and Fusion Center, leveraging extensive research to enhance its development efforts. By designing and building fusion machines, Commonwealth Fusion aims to provide limitless and clean energy, contributing to the global transition toward sustainable energy sources.

RWDC Industries

Series B in 2021
RWDC Industries Ltd develops and manufactures medium chain length polyhydroxyalkanoate (mcl-PHA) biopolymers. It develops polyhydroxyalkanoate (PHA) emulsion coating, a water-based PHA emulsion for paper and paperboard that can replace polyethylene (PE) in plastic-lined food packaging and thermoplastic replacement technologies, which allows for direct drop-in-replacement for existing petroleum based plastic items such as polypropylene straws, polystyrene containers, coffee cups and lids, utensils, fibers and polyethylene bags. The company was founded in 2015 and is based in Singapore.

SaladStop!

Series B in 2021
SaladStop! is a pioneer in the healthy food movement in Singapore and aims to serve the best tasting and most nutritious salads, wraps and grain bowls. SaladStop! currently operates 23 outlets in Singapore and Manila and quickly approaching their vision of becoming the world’s leading nutrition, health and wellness company, expanding to Indonesia and Japan later this year.

Arbor Biotechnologies

Series B in 2021
Arbor Biotechnologies operator of a bio-discovery company intended to provide human diagnostic development service. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.

FTX

Series B in 2021
FTX Trading LTD operates a cryptocurrency derivatives exchange and trading platform for traders and investment professionals. Its platform offers futures trading, leveraged tokens, and an OTC portal. The company’s platform supports quarterly and perpetual futures on various cryptocurrencies and altcoins, such as bitcoin, ether, binance coin, and tether, as well as various altcoin, midcap, and other indices. The company was founded in 2017 and is based in San Francisco, California.

Innovusion

Series B in 2021
Innovusion is a leading developer of image grade LiDAR sensor systems for the level 4 and 5 of the autonomous vehicle and ADAS markets. Their unique combination of range, resolution, hardware accelerated sensor fusion, compact size, ease of integration and cost effectiveness makes our products the ideal choice for the most demanding applications. We are venture-backed and headquartered in the heart of Silicon Valley.

Woebot Health

Series B in 2021
Woebot Health is a San Francisco-based company founded in 2017 that specializes in developing mental health chatbot applications. Its primary mission is to make mental health care widely accessible through innovative technology. The company's chatbot engages users in conversation, providing tailored responses to help reduce symptoms of mood-based disorders. By combining effective therapeutic techniques with advanced digital tools, Woebot Health offers a suite of digital therapeutics and behavioral health products designed to be responsive and targeted to individual needs. The company has received funding from several venture capital firms, including New Enterprise Associates, Jazz Venture Partners, and Social Discovery Ventures, as well as contributions from Andrew Ng's AI Fund.

FTX

Series B in 2021
FTX Trading LTD operates a cryptocurrency derivatives exchange and trading platform for traders and investment professionals. Its platform offers futures trading, leveraged tokens, and an OTC portal. The company’s platform supports quarterly and perpetual futures on various cryptocurrencies and altcoins, such as bitcoin, ether, binance coin, and tether, as well as various altcoin, midcap, and other indices. The company was founded in 2017 and is based in San Francisco, California.

Fortera

Series B in 2021
Fortera develops a process for recreating the natural material that provides significant economic savings. It Founded in 2017 and is based in Campbell, California.

Einride

Series B in 2021
Einride AB is a freight mobility company that specializes in the transportation of goods using innovative technologies. Founded in 2016 and headquartered in Stockholm, Sweden, with additional offices in Gothenburg and Palo Alto, Einride focuses on developing electric and autonomous logistics solutions. The company's flagship products include Einride Pods, which are electric trucks designed for transporting a variety of cargo, including pallets, timber, and perishable goods. Einride also provides clients with tools to plan, order, and track sustainable transport, aiming to redefine logistics through intelligent freight mobility solutions.

Innovusion

Series B in 2021
Innovusion is a leading developer of image grade LiDAR sensor systems for the level 4 and 5 of the autonomous vehicle and ADAS markets. Their unique combination of range, resolution, hardware accelerated sensor fusion, compact size, ease of integration and cost effectiveness makes our products the ideal choice for the most demanding applications. We are venture-backed and headquartered in the heart of Silicon Valley.

Manner

Series B in 2021
Manner is a specialty coffee chain based in Shanghai, China, founded in 2015. The company operates coffee shops across multiple cities, including Shenzhen, Beijing, Chengdu, and Suzhou, offering a variety of beverages such as coffee, tea, smoothies, juices, and desserts. Manner emphasizes making quality coffee accessible and affordable to all customers while also committing to environmental sustainability. To promote eco-friendly practices, Manner incentivizes customers to bring non-disposable cups by providing a discount on their purchases. The company aims to deliver delicious drinks at fair prices while addressing social responsibility through its environmental initiatives.

pairwise, Inc.

Series B in 2021
Pairwise, Inc. is a food and technology company focused on improving the quality of fruits and vegetables through innovative agricultural gene editing techniques. Founded in 2017 and based in San Diego, California, Pairwise collaborates with food and agriculture companies to develop new crop varieties, including leafy greens, berries, and stone fruits. The company utilizes advanced tools and traits licensed from Harvard and Massachusetts General Hospital, leveraging expertise from a team with backgrounds in agriculture, consumer packaged goods, and research. With a commitment to fostering a healthier world, Pairwise aims to introduce its first products in the coming years, contributing to advancements in food technology and sustainable agriculture.

Locanabio

Series B in 2020
Locanabio, Inc., is an RNA-targeting gene therapy company focused on developing therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.

v2food

Series B in 2020
v2food is a plant-based meat startup that produces legume-based meat alternatives. The company v2 product is a delicious, nutritious alternative for anyone who loves the taste of meat but doesn’t want to get it from animals. It is a safe space to connect with like-minded people and create positive relationships with food that will help them feed the planet in a sustainable way. v2food was founded by Nick Hazell in 2019 and is based in Sydney, New South Wales, Australia.

Nuvia

Series B in 2020
Nuvia develops processors intended to create high-performance silicon design for a compute-intensive world. It designs processing chipsets for data center servers, thereby delivering a faster, power-efficient, and secure experience to existing data center processors. Manu Gulati, John Bruno, and Gerard Williams III launched Nuvia in Santa Clara, California in 2019.

Lu Daopei Medical Group

Series B in 2020
Lu Daopei Medical Group operates hospitals in China. The company operates department of BMT, department of general hematology, lymphoma and myeloma center, and pathology and specialty hematology lab. Lu Daopei Medical Group was founded in 2002 and is based in Beijing, China.

Glympse Bio

Series B in 2020
Glympse Bio, Inc. is focused on developing modular nanoparticle sensors for diagnostics in fibrosis, cancer, immunology, and infectious diseases, as well as for monitoring drug response. The company utilizes engineered diagnostic agents that assess disease states within the body and convey this information to urine for analysis. Its flagship product, Glympse Inside, serves as a pan-disease engine intended to enhance disease monitoring and treatment response. Founded in 2015 and based in Cambridge, Massachusetts, Glympse Bio's innovative platform technology originated at MIT and is backed by a team of experts in nanomedicine and biomedical engineering.

JW Therapeutics

Series B in 2020
JW (Cayman) Therapeutics Co. Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. The company offers cell-based immunotherapies, including CAR-T treatments, which is a treatment method that uses human immune cells to fight cancer. Its lead product candidate is relmacabtagene autoleucel, an anti-CD19 CAR-T therapy for relapsed or refractory B-cell lymphoma. JW (Cayman) Therapeutics Co. Ltd was founded in 2016 and is headquartered in Shanghai, China.

Tropic Biosciences

Series B in 2020
Tropic Biosciences UK LTD is a biotechnology company focused on developing high-performing commercial varieties of tropical crops, specifically targeting the coffee and banana industries. Established in 2016 and headquartered in Norwich, United Kingdom, the company employs advanced non-GMO gene editing technologies to enhance crop performance while promoting grower wellbeing and consumer health. Through its innovative approach, Tropic Biosciences aims to improve sustainable agricultural practices and address the challenges faced by tropical crop producers.

Genor Biopharma

Series B in 2020
Genor BioPharma Co., Ltd., a biopharmaceutical company, develops and commercializes therapeutic monoclonal antibody (mAbs) and Fc-fusion protein drugs. It is developing two categories of mAb drugs, such as biosimilars and new molecular entities. The company develops products in the areas of cancer, autoimmune disease, and metabolic diseases. Genor BioPharma Co., Ltd. has a strategic collaboration with Ascentage Pharma. The company was founded in 2007 and is based in Shanghai, China. Genor BioPharma Co., Ltd. is a former subsidiary of Walvax Biotechnology Co.,Ltd.

Ascus Biosciences

Series B in 2020
Ascus Biosciences, founded in 2015 and headquartered in San Diego, California, focuses on developing a computational and genomics-based technology platform aimed at discovering and creating next-generation microbial products. The company's innovative approach leverages advanced data analysis and genomic insights to enhance the development of microbial solutions, catering to various applications in biotechnology and related fields.

ShopBack

Series B in 2020
ShopBack offers a one-stop lifestyle portal that powers smarter purchase decisions for consumers. Today, ShopBack is the dominant player in Southeast Asia’s e-commerce Cashback market, with an established presence in Singapore, Malaysia, Indonesia, the Philippines, Thailand, and Taiwan, powering over 1,000 orders per hour. ShopBack enhances shopping by providing up to 30% Cashback for consumers to boost their purchasing power while providing cost-effective marketing solutions for merchant partners. With over 1,300 merchant partners, including Uber, Expedia, and Lazada, ShopBack constantly strives to bring a smarter shopping experience to the consumers. In October 2015, ShopBack was awarded the winner of the Gold award in the Best Start-up (Growth Stage) category and Silver award in the Best Innovative Infocomm Products (Consumers) category at the 7th Singapore Infocomm Technology Federation (SiTF) Awards. This is the local start-up’s maiden voyage in industry awards, pitting against more than 300 nominations for the esteemed titles. The company was recently awarded the Emerging Enterprise Award in September 2016, jointly organized by The Business Times (Singapore) and OCBC Bank, which recognizes outstanding small and medium enterprises (SMEs) in Singapore.

Fabric

Series B in 2020
Fabric is developing an on-demand supply chain solution aimed at grocery retailers, enabling them to provide sustainable, one-hour delivery services to their online customers. The company has created Micro-Fulfillment Centers, which are urban, automated fulfillment facilities designed to optimize local distribution while maintaining cost-efficiency. By leveraging advanced robotics and artificial intelligence, Fabric redefines the fulfillment and delivery process in urban settings. This innovative approach addresses the challenges of last-mile delivery, allowing retailers to implement true on-demand services, significantly lower operational costs, and achieve enhanced scalability in their operations.

UPSIDE Foods

Series B in 2020
Memphis Meats develops meat produced directly from animal cells without the need to raise and slaughter actual animals that require significantly less caloric input, water, land, and energy than conventional meat production, enabling consumers to enjoy meat products that are clean and free from harmful chemicals. Founded by Uma Valeti and Nicholas Genovese in 2015, Memphis Meats is headquartered in San Francisco, California.

Soul Machines

Series B in 2020
Soul Machines Limited develops emotionally responsive avatars that augment and enrich the user experience for artificial intelligence (AI) platforms. The company’s products include Digital DNA Studio, which allows user to build custom digital people for customer care, sales and marketing, brand and influencer, product, wellbeing, people and performance, training and education, and digital innovation purposes. The company was incorporated in 2016 and is headquartered in Auckland, New Zealand with additional offices in San Francisco and Los Angeles, California; New York, New York; London, United Kingdom; Tokyo, Japan; and Melbourne, Australia.

Transcenta

Series B in 2020
Transcenta Holding Ltd. is a clinical-stage biotherapeutics company specializing in the research, development, and manufacturing of antibody-based therapeutics. Founded in 2019 and headquartered in Suzhou, China, Transcenta has additional facilities in major cities including Shanghai, Hangzhou, and Beijing, as well as in Waltham, Massachusetts, and Princeton, New Jersey. The company was formed through the merger of HJB and MabSpace Biosciences and focuses on developing innovative antibodies aimed at treating various conditions. Currently, Transcenta is advancing nine therapeutic antibody molecules targeting oncology and select non-oncology indications, including bone and kidney disorders.

Eigen Technologies

Series B in 2019
Eigen Technologies Limited specializes in developing software for data extraction and mining, utilizing machine learning algorithms to analyze and interpret text. Founded in 2014 and headquartered in London, with an additional office in New York, the company automates the extraction and classification of information from various types of documents, enabling clients in finance, law, and professional services to make informed decisions. By employing advanced natural language processing technology, Eigen recognizes patterns within text to provide accurate answers to specific queries and classify documents based on relevant attributes. This capability allows clients to meet regulatory requirements, assess risks, and make strategic decisions regarding asset portfolios. Eigen's solutions can be deployed on-premises or in cloud environments, integrating seamlessly into existing workflows and transforming unstructured qualitative data into actionable insights.

pureLiFi

Series B in 2019
pureLiFi develops technology for communication networks that integrates data and lighting utility infrastructures. It offers a LiFi enabled a device that converts the beam of lights into an electrical signal. The signal is then converted back into data. The company was founded in 2012 and is headquartered in Edinburgh.

Bowery Farming

Series B in 2019
Bowery Farming Inc., a farming company, provides post-organic produce. The company offers baby kale, blend, lettuce, arugula, kale mix, and basil products. It sells its products through grocery stores and restaurants. The company was founded in 2014 and is based in New York, New York.

Viela Bio

Series B in 2019
Viela Bio, Inc. is a clinical-stage biotechnology company based in Gaithersburg, Maryland, focused on developing treatments for severe inflammation and autoimmune diseases. Its lead product candidate, inebilizumab, is a humanized monoclonal antibody targeting CD19, aimed at treating conditions such as neuromyelitis optica spectrum disorder, kidney transplant desensitization, myasthenia gravis, and IgG4-related diseases. The company is also advancing additional candidates, including VIB4920 for kidney transplantation rejection and Sjögren’s syndrome, as well as VIB7734 for cutaneous lupus erythematosus. Viela Bio has formed a strategic collaboration with Mitsubishi Tanabe Pharma Corporation to develop and commercialize inebilizumab for autoimmune diseases across several countries in Asia. Founded in 2017, the company is dedicated to addressing unmet medical needs in the field of autoimmune disorders.

Gracell Biotechnologies

Series B in 2019
Gracell Biotechnologies Inc. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering and developing innovative cell therapies for cancer treatment. The company's lead product candidates include GC012F, a dual-targeted CAR-T therapy for multiple myeloma currently in Phase I trials; GC019F, which targets adult B cell acute lymphoblastic leukemia and is also in Phase I trials; and GC007F, aimed at B cell non-Hodgkin’s lymphoma, also in Phase I. Additionally, Gracell is developing GC027, a CAR-T candidate targeting adult T cell acute lymphoblastic leukemia, and GC007g, an allogeneic CAR-T therapy for relapsed or refractory B-ALL, both in Phase I trials. Beyond these, Gracell has a pipeline of earlier-stage product candidates targeting various cancers, including ovarian and breast cancer. Founded in 2017, Gracell Biotechnologies is committed to advancing cellular therapeutics to improve patient outcomes in hematological malignancies and solid tumors.

Perfect Day

Series B in 2019
Perfect Day, Inc. is a company that specializes in producing animal-free dairy products, including milk, cheese, yogurt, and ice creams. Founded in 2014 and headquartered in Emeryville, California, the company utilizes yeast fermentation of plant-based sugars to create dairy proteins that are nutritionally identical to those found in cow's milk. This innovative approach allows Perfect Day to offer products that replicate the taste, texture, and nutritional benefits of traditional dairy while avoiding the environmental and ethical concerns associated with animal agriculture. The company's offerings are sustainable, vegan, and free from antibiotics, cholesterol, and lactose, catering to consumers seeking healthier and more compassionate alternatives to conventional dairy.

Bowery Farming

Series B in 2018
Bowery Farming Inc., a farming company, provides post-organic produce. The company offers baby kale, blend, lettuce, arugula, kale mix, and basil products. It sells its products through grocery stores and restaurants. The company was founded in 2014 and is based in New York, New York.

Pivot Bio

Series B in 2018
Pivot Bio is a biotechnology company founded in 2010 and based in Emeryville, California. The company specializes in advancing crop nutrition through a deep understanding of the microbiome. By leveraging engineering principles and data science, Pivot Bio develops innovative solutions that utilize naturally occurring microbes to enhance crop yield and quality. Their proprietary ON Technology aims to provide essential nutrients to crops, specifically focusing on enabling microbes to fix and supply nitrogen for corn. This approach seeks to offer a sustainable alternative to traditional chemical fertilizers and pesticides, helping farmers improve their yields while addressing the nutritional needs of the growing global population. Through collaboration and communication, Pivot Bio is dedicated to transforming agricultural practices and contributing to a healthier planet.

Bitmain

Series B in 2018
Bitmain is a manufacturer of Bitcoin mining hardware and other related services. Bitmain was founded by several of the digital currency industry’s earliest players, and their team is comprised of passionate and pedigreed engineers, financial experts, and Bitcoin enthusiasts. Bitmain is headquartered in Beijing and has offices in San Francisco, Tel Aviv, Hong Kong, Chengdu and Shenzhen.

WeWork

Series B in 2018
WeWork, known as The We Company, is a commercial real estate firm that specializes in providing flexible workspaces and office services primarily for entrepreneurs and technology startups. Founded in 2010 and headquartered in New York, the company transforms buildings into dynamic environments that foster creativity, collaboration, and productivity. Its offerings include a variety of workplace solutions such as private offices, shared workspaces, and on-demand access to workstations, catering to diverse member needs. In addition to physical spaces, WeWork provides a range of services through partnerships, enabling members to work, live, and grow. The company also operates WeWork Labs, which supports early-stage startups by providing community and programming to aid their development. With a focus on inclusivity and community, WeWork aims to create an environment where members can thrive and innovate together.

SHIELD

Series B in 2018
SHIELD is a company that specializes in fraud management solutions, helping enterprises mitigate risks associated with fraudulent payments and accounts. Utilizing advanced technology, including trading algorithms and real-time pattern recognition, SHIELD effectively identifies fraudulent behaviors without human intervention. The company provides a range of services, including payment fraud prevention, account takeover protection, and promotional fraud mitigation. With a global client base that includes major enterprises such as Razer and Alibaba, SHIELD safeguards over seven billion devices and 500 million user accounts annually, fostering trust and safety in the digital landscape. Founded in 2007 and based in Singapore, SHIELD continues to enhance its offerings in fraud prevention, network security, credit intelligence, and identity verification.

Claroty

Series B in 2018
Claroty Ltd. is a cybersecurity company focused on protecting operational technology (OT) networks, which are critical for industrial operations. Established in 2014 and based in New York, Claroty provides a platform that enables engineers, operators, and cybersecurity professionals to secure and optimize these networks. The company specializes in identifying granular elements within OT environments, extracting essential data, and generating actionable insights to enhance security and operational efficiency. Its solutions effectively bridge the gap between information technology (IT) and OT, allowing organizations to leverage existing IT security measures to improve the safety and reliability of their industrial assets. Claroty's services are particularly beneficial for automated production sites and critical infrastructure, helping to mitigate significant security and financial risks. The company has gained recognition in the industry and has been adopted by leading industrial automation vendors, with deployments across all seven continents. Since its inception, Claroty has secured significant funding to advance its mission in the cybersecurity landscape.
Hangzhou Just Biotherapeutics, Ltd., also known as Just China, is a biotechnology company founded in 2016 and located in Hangzhou, China. The company specializes in developing antibody and recombinant protein biotherapeutics, focusing on accelerating the development of biomedicines while significantly reducing manufacturing costs. It excels in molecular design, process design, drug product design, and the design of manufacturing facilities. Initially a subsidiary of Just Biotherapeutics, Inc., it became a subsidiary of MabSpace Biosciences Co., Ltd. in January 2019.

Helix

Series B in 2018
Helix is a prominent population genomics company that operates at the intersection of clinical care, research, and data analytics. The company provides an end-to-end platform designed to facilitate genomic research and the incorporation of genomic data into healthcare practices. Helix operates one of the largest CLIA/CAP-certified next-generation sequencing laboratories and utilizes its proprietary Exome+™ assay to support various aspects of population genomics. These include recruitment and engagement, clinically actionable disease screening, and the return of results. Additionally, Helix engages in large-scale genetic analysis and viral surveillance, delivering actionable genetic insights that aid health systems, life sciences companies, payers, and government entities in enhancing patient care and informing public health decisions.

Rokid

Series B in 2018
Rokid Corporation is an artificial intelligence and robotics company founded in 2014, with its headquarters in Hangzhou, China, and research centers in Beijing and San Francisco. The company specializes in developing smart home devices, including Pebble and Alien, which utilize advanced AI and deep learning to facilitate voice and visual interactions. Rokid's products offer various functionalities, such as access to weather updates, smart home automation, music, and basic chat, enhancing user experience through multi-dimensional interaction. The company's focus on speech recognition, natural language processing, and image recognition allows its devices to cater to specific consumer needs. Additionally, Rokid has received recognition for its innovation, winning CES innovation awards consecutively in 2016 and 2017. This commitment to superior industrial design and user experience positions Rokid as a leader in the fields of robotics and AI technology.

Pear Therapeutics

Series B in 2018
Pear Therapeutics, Inc. focuses on developing and delivering clinically validated software-based therapeutics aimed at treating behavioral health disorders, including psychiatric and neurologic conditions. The company creates digital therapies for severe conditions such as addiction, schizophrenia, pain, post-traumatic stress disorder, anxiety, depression, and chronic insomnia. Its key products include mobile digital therapies that incentivize patients for completing treatment modules, reSET for substance use disorder, reSET-O for opioid use disorder, and Somryst for insomnia. Additionally, Pear Therapeutics offers PearConnect, a comprehensive patient services center that provides support for patients throughout their treatment journey, connects healthcare providers to resources, and assists insurance companies with claims processing. Founded in 2013, Pear Therapeutics is headquartered in Boston, Massachusetts, with an additional office in San Francisco, California.

Orchard Therapeutics

Series B in 2017
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company’s gene therapy approach seeks to transform a patient’s hematopoietic stem cells into a gene-modified drug product to treat the patient’s disease through a single administration. It provides Strimvelis, a gammaretroviral-based product for the treatment of adenosine deaminase-severe combined immunodeficiency (ADA-SCID). The company’s clinical development products comprise OTL-101 for the treatment of ADA-SCID; OTL-200 to treat metachromatic leukodystrophy; OTL-103 for the treatment of Wiskott-Aldrich syndrome; OTL-102 for X-linked chronic granulomatous disease; and OTL-300 for transfusion-dependent beta-thalassemia. Its preclinical programs include OTL-203 for mucopolysaccharidosis type I, OTL-201 for mucopolysaccharidosis type MPS-IIIA, and OTL-202 for mucopolysaccharidosis type IIIB. The company was formerly known as Orchard Rx Limited. Orchard Therapeutics plc was founded in 2015 and is headquartered in London, the United Kingdom.

Arterys

Series B in 2017
Arterys Inc. is a technology company specializing in medical imaging analytics, aiming to enhance patient care through innovative solutions. Founded in 2007 and headquartered in San Francisco, California, with additional offices in Calgary and Paris, Arterys offers a cloud-based, AI-powered platform that enables radiologists to visualize and quantify blood flow in the body. Its product lineup includes Cardio AI for cardiac imaging, Lung AI for lung analysis, Liver AI for liver diagnostics, and Chest/MSK AI for detecting various thoracic and musculoskeletal conditions. The platform is fully web-based and FDA-cleared, providing clinicians with tools for automatic and interactive reporting. Additionally, the Arterys PHI Service allows physicians to access patient data remotely, further supporting efficient medical practices.

Genuity Science

Series B in 2017
Genuity Science is a contract genomics and data-sourcing organization based in Boston, Massachusetts, with additional offices in Dublin, Ireland, and Reykjavik, Iceland. The company collaborates with global biopharma firms to provide comprehensive discovery services that enhance precision health and improve patient outcomes. Its offerings encompass population-scale, disease-specific data sourcing, high-quality sequencing, and advanced statistical analysis, along with software tools for managing large datasets and artificial intelligence applications. Genuity operates state-of-the-art CAP/CLIA genomics laboratories in Woburn, Massachusetts, and Dublin, emphasizing a strong commitment to data stewardship and governance. The company focuses on exploring biological data insights, storage, interpretation, and scalable analytics, particularly in the central nervous system, cardiometabolic, and inflammatory disease sectors.
Hangzhou Just Biotherapeutics, Ltd., also known as Just China, is a biotechnology company founded in 2016 and located in Hangzhou, China. The company specializes in developing antibody and recombinant protein biotherapeutics, focusing on accelerating the development of biomedicines while significantly reducing manufacturing costs. It excels in molecular design, process design, drug product design, and the design of manufacturing facilities. Initially a subsidiary of Just Biotherapeutics, Inc., it became a subsidiary of MabSpace Biosciences Co., Ltd. in January 2019.

Homology Medicines

Series B in 2017
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing across a range of genetic disorders. The company’s various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, central nervous system, peripheral nervous system, bone marrow, muscle, and eye. Its lead product candidate is HMI-102, which is in Phase 1/2 pheNIX clinical trial, a gene therapy for the treatment of phenylketonuria (PKU) in adults. The company also develops HMI-103 for the treatment of PKU in pediatric patients; and HMI-202 to treat metachromatic leukodystrophy. Homology Medicines, Inc. was founded in 2015 and is based in Bedford, Massachusetts.

Within (VR/AR)

Series B in 2017
Within is the premier destination for innovative, entertaining, and informative story-based virtual reality and augmented reality. We bring together the best immersive experiences from the world's finest VR/AR creators—from gripping tales set in worlds of pure imagination to documentaries taking you further inside the news than ever before. Within supports all major headsets, including Oculus Quest, Rift, HTC Vive, Sony PlayStation VR, and Samsung Gear VR. To get started experiencing our ever-growing roster of content, just download our app for iPhone or Android today.

Genuity Science

Series B in 2017
Genuity Science is a contract genomics and data-sourcing organization based in Boston, Massachusetts, with additional offices in Dublin, Ireland, and Reykjavik, Iceland. The company collaborates with global biopharma firms to provide comprehensive discovery services that enhance precision health and improve patient outcomes. Its offerings encompass population-scale, disease-specific data sourcing, high-quality sequencing, and advanced statistical analysis, along with software tools for managing large datasets and artificial intelligence applications. Genuity operates state-of-the-art CAP/CLIA genomics laboratories in Woburn, Massachusetts, and Dublin, emphasizing a strong commitment to data stewardship and governance. The company focuses on exploring biological data insights, storage, interpretation, and scalable analytics, particularly in the central nervous system, cardiometabolic, and inflammatory disease sectors.

IguanaFix

Series B in 2016
Our mission is to simplify maintenance and field operations management providing flexibility and visibility to companies around the world. Over 40,000 technicians have completed more than one million jobs using our platform.

NIO

Series B in 2016
NIO Limited is a prominent player in the electric vehicle market, specializing in the design, manufacture, and sale of premium smart electric SUVs in various regions, including China, Hong Kong, the United States, the United Kingdom, and Germany. The company offers a range of models, including five, six, and seven-seater electric SUVs, and emphasizes user experience through innovative charging solutions and services. NIO provides several charging options, such as home charging solutions, battery swapping services, and mobile charging through dedicated trucks. In addition to vehicle sales, the company offers comprehensive after-sales services, including insurance, maintenance, roadside assistance, and data packages. NIO has formed strategic partnerships for the development of autonomous driving technologies and collaborates with manufacturers for model production. Founded in 2014 and headquartered in Shanghai, NIO aims to redefine the user experience in the electric vehicle sector while driving advancements in connectivity and artificial intelligence.

pureLiFi

Series B in 2016
pureLiFi develops technology for communication networks that integrates data and lighting utility infrastructures. It offers a LiFi enabled a device that converts the beam of lights into an electrical signal. The signal is then converted back into data. The company was founded in 2012 and is headquartered in Edinburgh.

Modern Meadow

Series B in 2016
Modern Meadow, LLC is a biofabrication company established in 2011 and headquartered in Brooklyn, New York. The company specializes in producing animal-free leather and other cultured products, such as meat alternatives, through innovative methods that eliminate the need for animal slaughter. By utilizing living cells and fermentation-based processes, Modern Meadow develops lightweight materials that provide superior color, performance, and durability, while also promoting lab-to-brand traceability. Their approach significantly reduces the inputs of land, water, energy, and chemicals, contributing to lower greenhouse gas emissions. This focus on sustainability enables customers to maintain the quality and appearance of materials without relying on petrochemical inputs or animal-derived substances.

AccuraGen Inc.

Series B in 2016
We have developed a high-sensitivity next-generation sequencing-based system for the the detection of cancer mutations in miniscule concentrations of circulating cell-free DNA (cfDNA) in blood. Our technology addresses the significant barriers associated with harnessing the information contained in cfDNA by combining our proprietary techniques in molecular biology and computational algorithm for error suppression. With our technology, nanogram quantities of highly-fragmented cfDNA can be amplified more than 1000-fold, and a panel of tens to hundreds of cancer-related genes can be screened with a sensitivity at the single-digit molecular level.

Team8

Series B in 2016
Team8 is a venture capital firm established in 2014 and headquartered in Tel Aviv, Israel, with an additional office in New York City. The firm specializes in building and investing in startups focused on enterprise technology, cybersecurity, data science, AI, and fintech. Team8 employs a unique model that combines in-house company builders with a network of experienced executives and industry leaders, particularly drawing from the expertise of Israel's elite tech and intelligence Unit 8200. This collaborative approach enables Team8 to identify significant market challenges, develop innovative solutions, and accelerate the growth of new ventures. The firm targets early-stage investments, including seed and Series A and B rounds, and is backed by prominent global companies such as Microsoft, Walmart, Cisco, Barclays, and Moody's. Through its initiatives, Team8 aims to transform the technological landscape by co-founding and supporting companies that drive digital innovation and enhance the capabilities of existing financial and technological institutions.

HELIX

Series B in 2015
HELIX, formerly Flux, was the first spin-out of Google X. Initially focused on generative building design to automate planning and design of sustainable buildings, HELIX pivoted in 2019 to attack the high cost and complexity of digitizing buildings. Based in Oakland, CA, HELIX built the HELIX Creator platform to enable architects, engineers, builders, and owner-operators to use LiDAR and photogrammetry to capture accurate building geometry and convert it into usable plans and models. HELIX users need accurate 2D and 3D information and access to documents and data related to the building without delays. HELIX is used to evaluate buildings' potential, plan for renovation, document buildings in detail for disaster planning and more. HELIX believes that for Digital Twins to achieve their potential the data must be accurate, intuitive to access and easy to keep up to date.

Jet

Series B in 2015
Jet operates a smart shopping platform that allows its member to shop online from various retailers. It enables users to shop products in various categories, such as household products, health and beauty, grocery, baby, pet supplies, electronics, home and furniture, appliances, patio and garden, toys and video games, books, music and movies, office products, automotive, sports and fitness, clothing, shoes and accessories, jewelry and watches, arts, and crafts and hobbies. Mark Lore, Mike Hanrahan, and Nate Faust founded Jet in April 2014, with its headquarters in Hoboken in New Jersey. Jet operates as a subsidiary of Wal-Mart Stores as of September 19, 2016.

Adyen

Series B in 2014
Adyen N.V. operates a comprehensive payments platform that integrates various services essential for processing transactions. The company provides a suite of solutions including payment gateway, risk management, processing, acquiring, and settlement services. Its platform supports merchants across multiple sales channels—online, mobile, and in-store—by connecting them directly to major payment networks like Visa and Mastercard, while also offering valuable data insights. Founded in 2006 and headquartered in Amsterdam, Adyen has expanded its presence globally with offices in numerous countries, including Brazil, Singapore, the United Kingdom, Canada, Australia, and the United States. The company's infrastructure is designed to facilitate seamless payment authorization for merchants of diverse verticals.

Visterra

Series B in 2014
Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. and changed its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.

Krux

Series B in 2014
Krux helps companies deliver personalized commerce, media, and marketing experiences to the right people, in the right way, at the right time across all devices, browsers, and operating systems. Krux’s cloud-based data management platform (DMP) unifies people data from multiple screens and sources into a single view of the individual, analyzes the data to understand each individual’s preferences, and activates the data across every channel (desktop, mobile, social, display, web, set-top) in real time. Founded in 2010, Krux interacts with over two billion browsers and devices worldwide, serves over 20 billion page views per month, and processes more than 1.5 billion CRM records per month. Krux is a venture-backed company headquartered in San Francisco with offices across four continents. Krux clients such as Kellogg, Time Warner, and Meredith have achieved a 10x return or higher on their investment. Follow Krux on Facebook, Twitter, LinkedIn and Google+.

iTutorGroup

Series B in 2014
ITutorGroup provides online education platforms for students and business professionals. Its products include VIPABC, TutorABC, VIPABCJr, and TutorABCJr for English-language learning, TutorMing for Mandarin Chinese language learning, and LiveH2H for live translations in multiple languages. Eric Yang, Jerry Huang, and Ming Yang founded ITutorGroup in 1998, with headquarters in Taipei City in Taiwan. It has additional offices in Shanghai in China and Santa Clara in California.

Xiaomi

Series B in 2011
Xiaomi Corporation is an internet company based in Beijing that specializes in the manufacture and distribution of smartphones, consumer electronics, and internet services. Founded in 2010, Xiaomi operates through several segments, including Smartphones, IoT and Lifestyle Products, Internet Services, and Others. The Smartphones segment focuses on selling a range of mobile devices, while the IoT and Lifestyle Products segment includes smart TVs, laptops, AI speakers, and various lifestyle items. The Internet Services segment offers advertising and value-added services, and the Others segment provides hardware repair services. Xiaomi aims to create a comprehensive user experience by integrating user feedback into product design and continuously innovating its offerings. It also engages in wholesale and retail activities, software and hardware development, and operates retail stores and service centers in multiple countries, including India, Russia, and various European nations. The company's commitment to providing high-quality products at competitive prices has fostered a loyal customer base both in China and internationally.

SecondMarket

Series B in 2010
SecondMarket simplifies private securities transactions. Our online portal enables private companies and investment funds to customize, control and seamlessly execute primary and secondary transactions. SecondMarket is backed by premier investors, including FirstMark Capital, The Social+Capital Partnership, Li Ka-shing Foundation, Temasek Holdings, New Enterprise Associates (NEA) and Silicon Valley Bank. SecondMarket is a registered broker-dealer and member of FINRA, MSRB and SIPC and a SEC registered alternative trading system (ATS) for private company stock. For more information, please visit www.secondmarket.com. Follow us on Twitter and like us on Facebook.

9You

Series B in 2008
Nineyou is an interactive entertainment portal based in Shanghai, China, catering to Chinese language internet users globally. The platform offers a comprehensive range of online game services, including MMORPGs, casual games, and mobile games. In addition to gaming, Nineyou features fashionable digital entertainment content, chat and community services, and an Avatar System, enhancing user interaction and engagement. The company also provides wireless value-added services and other premium offerings, positioning itself as a multifaceted hub for digital entertainment and social interaction.

Inspired Capital

Series B in 2003
Inspired Capital plc specializes in providing a range of lending products tailored for small and medium enterprises (SMEs) in the United Kingdom. Their offerings include business cash advances, asset finance, trade finance, construction finance, recruitment finance, transport finance, enterprise finance guarantees, factoring, and invoice discounting. The company aims to simplify the borrowing process, ensuring that SMEs can access the necessary funds quickly and with minimal hassle. Inspired Capital's products are designed to support various business needs, such as expanding operations, hiring staff, investing in equipment, or maintaining cash flow. Established in Bristol, the company was previously known as Renovo Group plc before rebranding in August 2014 and has since transitioned to a private entity as of August 2015.

ShipServ

Series B in 2000
ShipServ helps buyers and suppliers of shipping supplies and services find each other faster and do business more efficiently. Our products and services bring the global community together online, in print, on ship and in person. We’re maritime industry innovators with the industry’s largest online trading platform, the most used supplier search engine, the leading ordering guide and the world’s first online maritime ad network. The high volumes of sourcing, trading and search data that our community shares every day helps us to deliver better results and more accurate information. No one facilitates the intelligent, trustworthy matching of suppliers and buyers better than ShipServ.

Exent

Series B in 2000
Exent Technologies Ltd. is a digital entertainment media company based in Petah Tikva, Israel, specializing in the marketing, merchandising, distribution, and monetization of mobile and PC games. The company operates GameTanium, a subscription service that grants access to a wide array of Android games on various devices including smartphones, tablets, and televisions. Additionally, Exent runs FreeRide Games, a platform offering over 400 premium, full-version PC casual games at no cost to users, supported by ads. Exent delivers games on demand for mobile operators, telecommunications providers, device manufacturers, and web portals, partnering with major industry players to enhance their services. With a portfolio of more than 2,500 games from over 150 publishers, Exent’s offerings are designed to boost user engagement and revenue for its partners. The company has garnered investments from notable firms, including Intel Capital and Cisco. Founded in 1992, Exent continues to innovate in the gaming space, providing both subscription-based and free gaming experiences to millions of players worldwide.

Savi Technology

Series B in 2000
Savi is the leader in applying big data analytics, data science, and machine learning to in-transit visibility. We develop innovative Internet of Things (IoT) and in-transit visibility solutions for the largest and most complex supply chains in the world. More than 1,000 companies and government organizations depend on Savi applications to reduce supply chain disruptions, improve delivery performance, and decrease logistics costs. For more information about Savi visit www.savi.com.

Terawave Communications

Series B in 2000
Terawave Communications, Inc. manufactures converged access and multi-service networking solutions. Its multi-service aggregation and passive optical network products provide data, voice, video, and circuit service convergence solutions. The company serves service providers, government agencies, and enterprise customers in the United States, Europe, Asia, Africa, and Latin America. Terawave Communications has locations in North America, Europe, and Asia. The company was founded in 1998 and is based in Hayward, California with additional offices in the United States of America, Canada, Asia, and Europe. As of October 25, 2007, Terawave Communications, Inc. is a subsidiary of Occam Networks Inc. (NasdaqNM:OCNW).